Piringer 2017.

Study name	Phase III randomised trial of endurance exercise following adjuvant chemotherapy for colorectal cancer "aBCSG C08‐II trial"
Methods	Study design: RCT Country where study is being conducted: Austria
Participants	788 patients with newly diagnosed, locally advanced colorectal cancer after adjuvant chemotherapy
Interventions	Intervention details: one year endurance exercise intervention Comparator details: usual care while maintaining habitual physical activity levels
Outcomes	Primary: Disease‐free survival Secondary: Recurrence‐free survival Overall survival Physical activity end points PROMS Cost‐effectiveness Utility and safety Time points measured: not reported
Starting date	Not known
Contact information	Not known
Notes	Supplement in magazine of European Medical Oncology

BMI: body mass index; ECOG: Eastern Oncology Cooperative Group; EORTC QLQ‐C30 ‐ European Organisation for Research and Treatment of Cancer Quality of life; FACIT‐F ‐ Functional Assessment of Chronic Illness Therapy‐Fatigue; IRB‐approved; institutional review board approved; LAR‐low anterior resection; OEE‐ Outcome Expectations for Exercise Scale; PROMIS‐ patient reported outcome measures information system, PROMIS PF ‐ patient reported outcome measures information system physical function; PROMIS PI‐patient reported outcome measures information system pain interference; PROMS‐ patient reported outcome measures; PSEFSM‐ perceived self‐efficacy for fatigue self‐management TNM‐ classification of malignant tumours; Tx‐ treatment QoL: quality of life; RCT: randomised controlled trial; UK: United Kingdom; USA: United States of America